Concepedia

Gregg Masters

GM

8

Publications

406

Citations

8

H-Index

2000

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Gregg Masters is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and tumor microenvironment.

Top concepts

MedicineImmunologyPharmacologyImmunotherapyTumor BiologyTumor MicroenvironmentOncologyCancer TherapyTumor ImmunityGynecology

Publications per year

2000–2017

8

Publications

8

Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

Margaret K. Callahan, Gregg Masters, Christine A. Pratilas et al. · Cancer Immunology Research · 2013 · 117 citations · Full text

Cancer Immunosurveillance, Signal Transduction, Cell Regulation +14

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

Maria Jure–Kunkel, Gregg Masters, Emel Girit et al. · Cancer Immunology Immunotherapy · 2013 · 84 citations · Full text

Chemotherapeutic Agents, Therapeutic Synergy, Cancer Immunosurveillance +15

Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds

Walter R. Perkins, Imran Ahmad, Xingong Li et al. · International Journal of Pharmaceutics · 2000 · 70 citations

Nanoparticles, Nanomedicine, Engineering +5

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models

Katherine E. Lewis, Mark Selby, Gregg Masters et al. · OncoImmunology · 2017 · 64 citations · Full text

Cancer Immunosurveillance, Antitumor Activity, Mouse Tumor Models +15

Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities

Shaukat Ali, Imran Ahmad, Andrew C. Peters et al. · Anti-Cancer Drugs · 2001 · 28 citations

Rows per page

1–5 of 8